FDA Approves CRISPR-Based Medicine For Treatment of Sickle Cell Disease

CRISPR-based gene editing therapy approved by the FDA for the first time

FDA approves a CRISPR-based medicine for treatment of sickle cell disease- In historic decision

New Drug That Could Extend Dogs' Lives Gets Closer to FDA Approval